GIULIA GRECOa,*, PAULA LORGELLYb and INTHIRA YAMABHAIc a London School of Hygiene & Tropical Medicine, London, UK b Centre for Health Economics, Monash University, Melbourne, Victoria, Australia c Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Bangko

The use of off-label medicines is an unexplored area for healthcare priority setting, though it is common practice in countries and can have a significant positive or negative effect on health outcomes and the efficiency of health care systems. It is therefore important to have a rational an

(Reuters) – Swiss drugmaker Novartis told India’s top court it had demonstrated the improved efficacy of its cancer drug Glivec as the final hearing began on Tuesday of a patent case that could change the rules for the country’s healthcare sector.A patent would recognize Novartis’ property rights, i

(Reuters) – An experimental drug from Novartis may help up to half of heart failure patients for whom no effective treatment is available, although the evidence so far is indirect.Results of a mid-stage clinical trial of the drug known as LCZ696, unveiled on Sunday, gauged its effectiveness by measu

Digital health technologies (DHTs) represent various products used in the healthcare system, including software, applications (apps) and online platforms benefiting individuals and the wider health and social care system. It is a field characterised by complexity and dynamism. The English digital

Executive Summary Digital health in Korea encompasses a wide range of technologies and services yet lacks a clear legal definition. The Korea Institute for Industrial Economics & Trade (KIET) classifies digital health into hardware, software, and service categories, reflecting the diverse lan

Digital health interventions (DHIs), such as electronic decision support tools, telemonitoring, or mobile health (mHealth) apps, have the potential to address health system challenges that limit the achievement of universal health coverage (UHC). Regional economic development and a growing ageing

Executive Summary Digital health technology (DHT) offers the potential to expand universal health coverage (UHC) by answering healthcare needs through a wide range of technology applications for instance artificial intelligence, big data, and machine learning. The adoption of DHT is not a new con

Executive Summary Australia has a history of innovation, which is reflected in the breadth of health technologies that are increasingly available in the country’s digital health landscape. This breadth of digital health technologies can be categorised across four domains: Software as a Medical De

To understand the digital health landscape in different countries from national strategy and regulation to HTA evaluation, adoption, and challenges. The objective is to use this information to better inform digital health policy in Thailand as well as to create a reference case to conduct HTA for digital health technologies.